Perspective Therapeutics
Perspective Therapeutics, Inc., together with its subsidiaries, develops precision-targeted alpha therapies (TAT) for oncology that treats cancer patients across multiple tumor types comprising metastatic disease. The company discovers, designs, and develop its initial program...
Perspective Therapeutics Logo
About Perspective Therapeutics
Perspective Therapeutics, Inc. operates as a biotech company. The Company develops cesium-131 brachytherapy seeds and has a proprietary technology that utilizes the isotope lead-212 to deliver powerful alpha radiation specifically to cancer cells via specialized targeting peptides. Perspective Therapeutics serves customers worldwide.
Address
2401 Elliott Avenue, Suite 320
Seattle, 98121
United States
Year founded
2018
Number of employees
100-200
Report inaccurate data
Request an update to help us keep the brand up-to-date.
